Abdulaziz Alsharif

Papers

1

Total Citations

4

H-Index

1

About

Dr. Abdulaziz Alsharif is a pioneering researcher at the intersection of neurodevelopment, pharmacology, and advanced biofabrication. His work centers on understanding how widely prescribed neurological drugs affect embryonic brain development, employing cutting-edge three-dimensional (3D) culture systems and robotic bioprinting technologies. His most cited study, "Investigating the effect of pregabalin on neuronal development using ultrashort self-assembling peptides," introduces a novel high-throughput platform that combines ultrashort self-assembling peptide scaffolds with robotic 3D bioprinting to model cortical neuron development. This work directly addresses a critical gap in prenatal pharmacology—the poorly understood effects of pregabalin on fetal brain development when taken during pregnancy. By creating more physiologically relevant 3D neuronal cultures, Dr. Alsharif's research provides a powerful tool for drug safety screening and developmental neurobiology. His innovative integration of biomaterials engineering with automated bioprinting has opened new avenues for studying neurodevelopmental toxicity, earning recognition for its methodological rigor and translational potential. With his work accumulating citations and setting new standards for in vitro neural modeling, Dr. Alsharif is establishing himself as a leading voice in the safe application of neurological therapeutics during pregnancy.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Investigating the effect of pregabalin on neuronal development using ultrashort self-assembling peptides: Assessing 3D neuronal cultures with high throughput robotic 3D bioprinting
4 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago